Generics Challenge FDA's Decision On Pfizer Drug - Seeking Alpha: "Aaron F. Barkoff submits: Apparently not too many companies other than Pfizer (PFE) are happy with the FDA's decision last week regarding Norvasc (amlodipine besylate) exclusivity.
On Monday, Mylan (MYL), Apotex, and Teva (TEVA) all filed motions with the U.S. District Court for the District of Columbia for injunctive relief from FDA's decision. Yesterday, everyone filed briefs in opposition to each others' motions."
